Vascular Alterations Among Young Adults with SARS-CoV-2
Overview
Physiology
Authors
Affiliations
While SARS-CoV-2 primarily affects the lungs, the virus may be inflicting detriments to the cardiovascular system, both directly through angiotensin-converting enzyme 2 receptor and initiating systemic inflammation. Persistent systemic inflammation may be provoking vascular dysfunction, an early indication of cardiovascular disease risk. To establish the potential effects of SARS-CoV-2 on the systemic vasculature in the arms and legs, we performed a cross-sectional analysis of young healthy adults (control: 5 M/15 F, 23.0 ± 1.3 y, 167 ± 9 cm, 63.0 ± 7.4 kg) and young adults who, 3-4 wk prior to testing, had tested positive for SARS-CoV-2 (SARS-CoV-2: 4 M/7 F, 20.2 ± 1.1 y, 172 ± 12 cm, 69.5 ± 12.4 kg) (means ± SD). Using Doppler ultrasound, brachial artery flow-mediated dilation (FMD) in the arm and single passive limb movement (sPLM) in the leg were assessed as markers of vascular function. Carotid-femoral pulse wave velocity (PWVcf) was asvsessed as a marker of arterial stiffness. FMD was lower in the SARS-CoV-2 group (2.71 ± 1.21%) compared with the control group (8.81 ± 2.96%) ( < 0.01) and when made relative to the shear stimulus (SARS-CoV-2: 0.04 ± 0.02 AU, control: 0.13 ± 0.06 AU, < 0.01). The femoral artery blood flow response, as evidenced by the area under the curve, from the sPLM was lower in the SARS-CoV-2 group (-3 ± 91 mL) compared with the control group (118 ± 114 mL) ( < 0.01). PWVcf was higher in the SARS-CoV-2 group (5.83 ± 0.62 m/s) compared with the control group (5.17 ± 0.66 m/s) ( < 0.01). Significantly lower systemic vascular function and higher arterial stiffness are evident weeks after testing positive for SARS-CoV-2 among young adults compared with controls. This study was the first to investigate the vascular implications of contracting SARS-CoV-2 among young, otherwise healthy adults. Using a cross-sectional design, this study assessed vascular function 3-4 wk after young adults tested positive for SARS-CoV-2. The main findings from this study were a strikingly lower vascular function and a higher arterial stiffness compared with healthy controls. Together, these results suggest rampant vascular effects seen weeks after contracting SARS-CoV-2 in young adults.
Chen J, Smith K, Xu Q, Ali T, Cavallazzi R, Ghafghazi S J Vasc Ultrasound. 2024; 48(2):95-102.
PMID: 39641110 PMC: 11619815. DOI: 10.1177/15443167231210357.
Graham E, DIsabel S, Lofrano-Porto A, Smith D Int J Environ Res Public Health. 2024; 21(10).
PMID: 39457356 PMC: 11508007. DOI: 10.3390/ijerph21101383.
Ammar M, Ben Said N, Ben Said Y, Abdelsalam A, Levushkin S, Laptev A J Clin Med. 2024; 13(19).
PMID: 39408050 PMC: 11477989. DOI: 10.3390/jcm13195990.
Chloroquine: Rapidly withdrawing from first-line treatment of COVID-19.
Jia Y, Tian W, Li Y, Teng Y, Liu X, Li Z Heliyon. 2024; 10(17):e37098.
PMID: 39281655 PMC: 11402237. DOI: 10.1016/j.heliyon.2024.e37098.
Knee osteonecrosis after SARS-CoV-2 infection: a systematic case-based review.
Za P, Papalia G, Russo F, Vasta S, Vadala G, Papalia R Ann Jt. 2024; 9:31.
PMID: 39114419 PMC: 11304089. DOI: 10.21037/aoj-23-67.